Motif Foodworks, formerly known as Motif, is a food ingredients company that uses biotechnology to brew proteins and nutrients, for more delicious and sustainable foods that is headquartered in Boston, Massachusetts and was founded in 2019 as a subsidiary of Ginkgo Bioworks. Motif Foodworks uses fermentation to brew proteins and nutrients.
February 26, 2019 Motif Foodworks completed their series A funding round with $90 million in funding from Fonterra, Louis Dreyfus Company, and Viking Global Investors. Ginkgo Bioworks launch Motif Foodworks after completing raising their series A funding round to begin developing alternative proteins and other ingredients for global food companies using biotechnology and fermentation.
On August 19, 2019 Motif Foodworks completed a growth equity funding round where the company received $27.5 million in funding from General Atlantic (lead investor) and CPT Capital. After receiving this round of growth equity the company rebranded from Motif to Motif Foodworks to better reflect the companies technological partnership with Ginkgo Bioworks. The company will be using their growth equity funding to accelerate their research and development, expand academic collaborations, hire more science and regulatory staff, and speed up the product pipeline for the alternative protein products.
$90m Series A. Investors include Fonterra Ventures and Louis Dreyfus.
Motif Foodworks raises a $90,000,000 series A round from Fonterra Ventures, Louis Dreyfus Company, Breakthrough Energy Ventures and Viking Global Investors.
Motif Foodworks was founded.
Motif Ingredients Launches With $90M To Make Meatless Protein
Motif Ingredients raises $27.5m, rebrands as Motif FoodWorks
August 19, 2019
Documentaries, videos and podcasts
- Impossible FoodsImpossible Foods is a plant-based meat company making meat and dairy products that are made to look and feel like animal products by manufacturing heme, the oxygen binding molecule found in blood, using engineered yeast grown in bioreactors.
- Ginkgo BioworksGinkgo Bioworks is a biotechnology company using machine learning techniques and lab automation to engineer microorganisms as a service.